Production (Stage)
Mustang Bio, Inc.
MBIO
$1.24
-$0.01-0.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.22M | -223.00K | 1.40M | 1.53M | 1.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 253.00K | -26.00K | 1.46M | 5.89M | 5.23M |
| Operating Income | -253.00K | 26.00K | -1.46M | -5.89M | -5.23M |
| Income Before Tax | -153.00K | -952.00K | -1.41M | -8.20M | -5.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -153.00K | -952.00K | -1.41M | -8.20M | -5.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -153.00K | -952.00K | -1.41M | -8.20M | -5.19M |
| EBIT | -253.00K | 26.00K | -1.46M | -5.89M | -5.23M |
| EBITDA | -219.00K | 77.00K | -1.41M | -5.61M | -4.95M |
| EPS Basic | -0.05 | -0.94 | -1.91 | -17.73 | -24.81 |
| Normalized Basic EPS | -0.03 | 0.06 | -1.20 | -7.50 | -15.51 |
| EPS Diluted | -0.05 | -0.94 | -1.91 | -17.73 | -24.81 |
| Normalized Diluted EPS | -0.03 | 0.06 | -1.20 | -7.50 | -15.51 |
| Average Basic Shares Outstanding | 2.86M | 1.01M | 736.80K | 462.50K | 209.20K |
| Average Diluted Shares Outstanding | 2.86M | 1.01M | 736.80K | 462.50K | 209.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |